| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 184.78M | 176.62M | 160.55M | 126.56M | 106.88M | 87.37M |
| Gross Profit | 122.55M | 112.40M | 110.28M | 112.33M | 101.78M | 72.93M |
| EBITDA | 41.87M | 37.70M | 35.91M | 34.48M | 31.78M | 20.49M |
| Net Income | 27.84M | 23.87M | 21.75M | 19.54M | 18.66M | 11.81M |
Balance Sheet | ||||||
| Total Assets | 3.15B | 3.11B | 3.05B | 2.94B | 2.69B | 1.76B |
| Cash, Cash Equivalents and Short-Term Investments | 330.55M | 64.84M | 432.72M | 453.14M | 957.14M | 398.03M |
| Total Debt | 0.00 | 248.04M | 238.44M | 203.35M | 88.45M | 60.29M |
| Total Liabilities | 2.85B | 2.83B | 2.80B | 2.71B | 2.47B | 1.62B |
| Stockholders Equity | 302.33M | 278.68M | 254.94M | 230.27M | 217.71M | 144.49M |
Cash Flow | ||||||
| Free Cash Flow | 44.39M | 22.32M | 17.36M | 46.85M | 30.27M | -23.34M |
| Operating Cash Flow | 44.96M | 23.40M | 20.98M | 49.74M | 36.10M | -19.09M |
| Investing Cash Flow | -38.77M | 101.16M | -98.75M | -448.23M | -208.33M | -130.27M |
| Financing Cash Flow | 48.92M | 23.15M | 80.41M | 281.93M | 185.95M | 228.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $374.37M | 12.02 | 9.42% | 5.43% | 5.76% | 21.85% | |
77 Outperform | $315.31M | 9.22 | 9.38% | 3.57% | 10.93% | 42.68% | |
75 Outperform | $391.87M | 11.57 | 9.63% | 2.55% | 6.92% | 26.93% | |
75 Outperform | $312.84M | 10.16 | 10.77% | 3.17% | 4.43% | -12.94% | |
74 Outperform | $299.67M | 9.50 | 11.86% | 5.24% | 10.46% | 18.70% | |
68 Neutral | $314.95M | 10.60 | 12.34% | 2.63% | 11.98% | -10.12% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On December 18, 2025, Colony Bankcorp’s board of directors extended the company’s existing stock repurchase program, originally approved in October 2022 and previously extended in December 2024, allowing the company to continue buying back up to $12 million of its common stock through the end of 2026. The company has repurchased 318,778 shares totaling $4.613 million since the program began, leaving $7.387 million available; the revised authorization preserves flexibility on timing, volume, and methods of repurchase, reflecting ongoing capital management priorities while allowing the company to adjust or terminate the program based on market conditions, regulatory requirements, and liquidity needs.
The most recent analyst rating on (CBAN) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.
On December 1, 2025, Colony Bankcorp, Inc. completed its merger with TC Bancshares, Inc., resulting in Colony Bankcorp becoming one of the leading community banks in the Southeast with approximately $3.7 billion in total assets. TC Bancshares shareholders received either cash or Colony common stock as part of the merger agreement. The merger is expected to expand Colony’s presence and deepen its service across key Georgia and Florida markets, with full integration anticipated in early 2026.
The most recent analyst rating on (CBAN) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.
On November 13, 2025, Colony Bankcorp, Inc. held a special meeting where shareholders approved the issuance of common stock for a merger with TC Bancshares, Inc., and the adjournment proposal to solicit additional proxies if needed. By November 17, 2025, the company announced it had received all necessary regulatory approvals for the merger, which is expected to close on December 1, 2025. This merger positions Colony as a leading community bank in the Southeast with approximately $3.8 billion in total assets, enhancing its market presence and service capabilities.
The most recent analyst rating on (CBAN) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.
On November 3, 2025, Colony Bankcorp, Inc. and its subsidiary, Colony Bank, entered into an Equity Distribution Agreement with Piper Sandler & Co. to issue and sell up to $40 million of the company’s common stock. The proceeds from this offering are intended for general corporate purposes, including supporting the bank’s lending and investing activities, repaying debt, and funding strategic initiatives. The agreement allows for flexible sales methods and includes customary terms and conditions, with no obligation for the company to sell any stock.
The most recent analyst rating on (CBAN) stock is a Buy with a $18.50 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.
Colony Bankcorp reported its third quarter 2025 financial results, highlighting a net income of $5.8 million, a slight decrease from the previous quarter. The company declared a quarterly cash dividend of $0.1150 per share. Despite a decrease in net income, operating net income increased to $8.2 million, driven by a rise in operating revenue and net interest margin expansion. The company also noted strong loan growth and a progressing merger with TC Federal Bank, expected to close in the fourth quarter. Total assets increased to $3.15 billion, with significant growth in loans and deposits. The company maintains a strong capital position, exceeding regulatory requirements.
The most recent analyst rating on (CBAN) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Colony Bankcorp stock, see the CBAN Stock Forecast page.